Lakefront Biotherapeutics NV (LKFT)
About Lakefront Biotherapeutics NV
Lakefront Biotherapeutics NV a biopharmaceutical company committed to improving the lives of people with severe diseases. It focuses on delivering medicines with transformational impact for patients by accelerating life-changing science and innovation in areas of high unmet need. Its pipelines includes GLPG3667, GLPG5101, and GLPG5301.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Market cap
- $1.8B
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $1.8B
- Shares outstanding
- 66.3M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Dec 18, 2008
Lakefront Biotherapeutics NV (LKFT) Stock Price
- Trading 10% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review Lakefront Biotherapeutics NV.
Write a review
Lakefront Biotherapeutics NV: frequently asked questions
Is Lakefront Biotherapeutics NV an American company?
Lakefront Biotherapeutics NV is a US-based company, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Is Lakefront Biotherapeutics NV publicly traded?
Yes — Lakefront Biotherapeutics NV is a publicly traded company. Its stock trades under the ticker symbol LKFT on the NASDAQ.
What does Lakefront Biotherapeutics NV do?
Lakefront Biotherapeutics NV is an American Pharmaceuticals company in the Health & Beauty sector.
